Search Results - Jon Zugazagoitia Fraile

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts)

    464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts) by Luis Paz-Ares, Santiago Ponce Aix, Alejandro Navarro, Reyes Bernabe, Maria Eugenia Olmedo, Trigo Jose Manuel, Jon Zugazagoitia Fraile

    Published 2021-11-01
    Article
    Save to List
    Saved in:

Search Tools: